Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors

Diego Centonze, Alessandro Usiello, Cinzia Costa, Barbara Picconi, Eric Erbs, Giorgio Bernardi, Emiliana Borrelli, Paolo Calabresi

Research output: Contribution to journalArticle

Abstract

Reduced glutamate-mediated synaptic transmission has been implicated in the pathophysiology of schizophrenia. Because antipsychotic agents might exert their beneficial effects against schizophrenic symptoms by strengthening excitatory transmission in critical dopaminoceptive brain areas, in the present study we have studied the effects of acute and chronic haloperidol treatment on striatal synaptic plasticity. Repetitive stimulation of corticostriatal terminals in slices induced either long-term depression or long-term potentiation (LTP) of excitatory transmission in control rats, whereas it invariably induced NMDA receptor-dependent LTP in animals treated chronically with haloperidol. Haloperidol effects were mimicked and occluded in mice lacking both D2L and D2S isoforms of dopamine D2 receptors (D2R-/-), in mice lacking D2L receptors and expressing normal levels of D2S receptors (D2R-/-;D2L-/-), and in mice lacking D2L receptors and overexpressing D2S receptors (D2L-/-). These data indicate that the blockade of D2L receptors was responsible for the LTP-favoring action of haloperidol in the striatum. In contrast, overexpression of D2S receptors uncovered a facilitatory role of this receptor isoform in LTP formation because LTP recorded from D2L-/- mice, but not those recorded from wild-type, D2R-/-, and D2R-/-;D2L-/- mice, was insensitive to the pharmacological blockade of D1 receptors. The identification of the cellular, molecular, and receptor mechanisms involved in the action of haloperidol in the brain is essential to understand how antipsychotic agents exert their beneficial and side effects.

Original languageEnglish
Pages (from-to)8214-8222
Number of pages9
JournalJournal of Neuroscience
Volume24
Issue number38
DOIs
Publication statusPublished - Sep 22 2004

Fingerprint

Long-Term Potentiation
Haloperidol
Antipsychotic Agents
Protein Isoforms
Corpus Striatum
Neuronal Plasticity
Brain
N-Methyl-D-Aspartate Receptors
Synaptic Transmission
Glutamic Acid
Schizophrenia
dopamine D2L receptor
Pharmacology
Depression

Keywords

  • Antipsychotics
  • Electrophysiology
  • LTD
  • LTP
  • Synaptic transmission
  • Transgenic mice

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. / Centonze, Diego; Usiello, Alessandro; Costa, Cinzia; Picconi, Barbara; Erbs, Eric; Bernardi, Giorgio; Borrelli, Emiliana; Calabresi, Paolo.

In: Journal of Neuroscience, Vol. 24, No. 38, 22.09.2004, p. 8214-8222.

Research output: Contribution to journalArticle

Centonze, Diego ; Usiello, Alessandro ; Costa, Cinzia ; Picconi, Barbara ; Erbs, Eric ; Bernardi, Giorgio ; Borrelli, Emiliana ; Calabresi, Paolo. / Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. In: Journal of Neuroscience. 2004 ; Vol. 24, No. 38. pp. 8214-8222.
@article{9f019b83a3314d11ae52b873ff8ae4f5,
title = "Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors",
abstract = "Reduced glutamate-mediated synaptic transmission has been implicated in the pathophysiology of schizophrenia. Because antipsychotic agents might exert their beneficial effects against schizophrenic symptoms by strengthening excitatory transmission in critical dopaminoceptive brain areas, in the present study we have studied the effects of acute and chronic haloperidol treatment on striatal synaptic plasticity. Repetitive stimulation of corticostriatal terminals in slices induced either long-term depression or long-term potentiation (LTP) of excitatory transmission in control rats, whereas it invariably induced NMDA receptor-dependent LTP in animals treated chronically with haloperidol. Haloperidol effects were mimicked and occluded in mice lacking both D2L and D2S isoforms of dopamine D2 receptors (D2R-/-), in mice lacking D2L receptors and expressing normal levels of D2S receptors (D2R-/-;D2L-/-), and in mice lacking D2L receptors and overexpressing D2S receptors (D2L-/-). These data indicate that the blockade of D2L receptors was responsible for the LTP-favoring action of haloperidol in the striatum. In contrast, overexpression of D2S receptors uncovered a facilitatory role of this receptor isoform in LTP formation because LTP recorded from D2L-/- mice, but not those recorded from wild-type, D2R-/-, and D2R-/-;D2L-/- mice, was insensitive to the pharmacological blockade of D1 receptors. The identification of the cellular, molecular, and receptor mechanisms involved in the action of haloperidol in the brain is essential to understand how antipsychotic agents exert their beneficial and side effects.",
keywords = "Antipsychotics, Electrophysiology, LTD, LTP, Synaptic transmission, Transgenic mice",
author = "Diego Centonze and Alessandro Usiello and Cinzia Costa and Barbara Picconi and Eric Erbs and Giorgio Bernardi and Emiliana Borrelli and Paolo Calabresi",
year = "2004",
month = "9",
day = "22",
doi = "10.1523/JNEUROSCI.1274-04.2004",
language = "English",
volume = "24",
pages = "8214--8222",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "38",

}

TY - JOUR

T1 - Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors

AU - Centonze, Diego

AU - Usiello, Alessandro

AU - Costa, Cinzia

AU - Picconi, Barbara

AU - Erbs, Eric

AU - Bernardi, Giorgio

AU - Borrelli, Emiliana

AU - Calabresi, Paolo

PY - 2004/9/22

Y1 - 2004/9/22

N2 - Reduced glutamate-mediated synaptic transmission has been implicated in the pathophysiology of schizophrenia. Because antipsychotic agents might exert their beneficial effects against schizophrenic symptoms by strengthening excitatory transmission in critical dopaminoceptive brain areas, in the present study we have studied the effects of acute and chronic haloperidol treatment on striatal synaptic plasticity. Repetitive stimulation of corticostriatal terminals in slices induced either long-term depression or long-term potentiation (LTP) of excitatory transmission in control rats, whereas it invariably induced NMDA receptor-dependent LTP in animals treated chronically with haloperidol. Haloperidol effects were mimicked and occluded in mice lacking both D2L and D2S isoforms of dopamine D2 receptors (D2R-/-), in mice lacking D2L receptors and expressing normal levels of D2S receptors (D2R-/-;D2L-/-), and in mice lacking D2L receptors and overexpressing D2S receptors (D2L-/-). These data indicate that the blockade of D2L receptors was responsible for the LTP-favoring action of haloperidol in the striatum. In contrast, overexpression of D2S receptors uncovered a facilitatory role of this receptor isoform in LTP formation because LTP recorded from D2L-/- mice, but not those recorded from wild-type, D2R-/-, and D2R-/-;D2L-/- mice, was insensitive to the pharmacological blockade of D1 receptors. The identification of the cellular, molecular, and receptor mechanisms involved in the action of haloperidol in the brain is essential to understand how antipsychotic agents exert their beneficial and side effects.

AB - Reduced glutamate-mediated synaptic transmission has been implicated in the pathophysiology of schizophrenia. Because antipsychotic agents might exert their beneficial effects against schizophrenic symptoms by strengthening excitatory transmission in critical dopaminoceptive brain areas, in the present study we have studied the effects of acute and chronic haloperidol treatment on striatal synaptic plasticity. Repetitive stimulation of corticostriatal terminals in slices induced either long-term depression or long-term potentiation (LTP) of excitatory transmission in control rats, whereas it invariably induced NMDA receptor-dependent LTP in animals treated chronically with haloperidol. Haloperidol effects were mimicked and occluded in mice lacking both D2L and D2S isoforms of dopamine D2 receptors (D2R-/-), in mice lacking D2L receptors and expressing normal levels of D2S receptors (D2R-/-;D2L-/-), and in mice lacking D2L receptors and overexpressing D2S receptors (D2L-/-). These data indicate that the blockade of D2L receptors was responsible for the LTP-favoring action of haloperidol in the striatum. In contrast, overexpression of D2S receptors uncovered a facilitatory role of this receptor isoform in LTP formation because LTP recorded from D2L-/- mice, but not those recorded from wild-type, D2R-/-, and D2R-/-;D2L-/- mice, was insensitive to the pharmacological blockade of D1 receptors. The identification of the cellular, molecular, and receptor mechanisms involved in the action of haloperidol in the brain is essential to understand how antipsychotic agents exert their beneficial and side effects.

KW - Antipsychotics

KW - Electrophysiology

KW - LTD

KW - LTP

KW - Synaptic transmission

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=4644333848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644333848&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.1274-04.2004

DO - 10.1523/JNEUROSCI.1274-04.2004

M3 - Article

C2 - 15385604

AN - SCOPUS:4644333848

VL - 24

SP - 8214

EP - 8222

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 38

ER -